Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 14, 2014; 20(22): 6815-6820
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6815
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6815
Synchronous colorectal cancer: Clinical, pathological and molecular implications
Alfred King-Yin Lam, Sally Sze-Yan Chan, Melissa Leung, Cancer Molecular Pathology, Griffith Health Institute, Griffith University, Gold Coast QLD 4222, Queensland, Australia
Author contributions: Lam AKY, Chan SSY and Leung M contributed to the manuscript.
Correspondence to: Alfred King-Yin Lam, Professor, Foundation Chair Professor and Head of Pathology, Cancer Molecular Pathology, Griffith Health Institute, Griffith University, Gold Coast QLD 4222, Queensland, Australia. a.lam@griffith.edu.au
Telephone: +61-7-56780718 Fax: +61-7-56780718
Received: October 3, 2013
Revised: December 6, 2013
Accepted: March 19, 2014
Published online: June 14, 2014
Processing time: 256 Days and 6.1 Hours
Revised: December 6, 2013
Accepted: March 19, 2014
Published online: June 14, 2014
Processing time: 256 Days and 6.1 Hours
Core Tip
Core tip: Synchronous colorectal carcinoma accounts for approximately 3.5% of colorectal carcinoma. This type of carcinoma has different clinical, pathological and molecular features from solitary colorectal carcinoma. There has been a lack of comprehensive reviews of this entity in recent years.